|
Volumn 57, Issue 9, 2014, Pages 2001-2002
|
Mortality after cancer among patients with diabetes mellitus: Effect of diabetes duration and treatment: (Questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
|
Author keywords
Cancer; Diabetes; Diabetes duration; Insulin; Mortality; Treatment
|
Indexed keywords
GLUCAGON LIKE PEPTIDE 1;
INSULIN;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
ANTIDIABETIC AGENT;
SULFONYLUREA;
CANCER DIAGNOSIS;
CANCER GROWTH;
CANCER MORTALITY;
CANCER SURVIVAL;
COMORBIDITY;
DIABETES MELLITUS;
DIABETIC PATIENT;
DISEASE ASSOCIATION;
DISEASE DURATION;
HUMAN;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
DISEASE CLASSIFICATION;
INSULIN DEPENDENT DIABETES MELLITUS;
TREATMENT DURATION;
COMPLICATION;
FEMALE;
MALE;
MORTALITY;
NEOPLASM;
DIABETES COMPLICATIONS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HUMANS;
MALE;
NEOPLASMS;
|
EID: 84905569445
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s00125-014-3281-1 Document Type: Letter |
Times cited : (1)
|
References (3)
|